Marion Odence-Ford
CIK: 0001845002
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
OptimizeRx Corp
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Aug 21, 2026OPRX
OptimizeRx Corp
Tax Payment(F)Direct1.5K shares at avg. $7.71$12K - Aug 20, 2026OPRX
OptimizeRx Corp
Award(A)Direct57.6K shares- - Feb 11, 2026OPRX
OptimizeRx Corp
Tax Payment(F)Direct1.4K shares at avg. $9.23$13K - Feb 11, 2026OPRX
OptimizeRx Corp
Exercise(M)Direct4K shares- - Dec 23, 2025OPRX
OptimizeRx Corp
Tax Payment(F)Direct4.1K shares at avg. $12.74$52K - Dec 19, 2025OPRX
OptimizeRx Corp
Exercise(M)Direct3.9K shares- - Dec 19, 2025OPRX
OptimizeRx Corp
Tax Payment(F)Direct1.2K shares at avg. $13.51$16K - Oct 3, 2025OPRX
OptimizeRx Corp
Exercise(M)Direct6.6K shares- - Oct 3, 2025OPRX
OptimizeRx Corp
Tax Payment(F)Direct2K shares at avg. $18.75$37K - Aug 21, 2025OPRX
OptimizeRx Corp
Award(A)Direct15.6K shares- - Mar 1, 2025OPRX
OptimizeRx Corp
Tax Payment(F)Direct268 shares at avg. $5.18$1K - Mar 1, 2025OPRX
OptimizeRx Corp
Exercise(M)Direct771 shares- - Feb 15, 2025OPRX
OptimizeRx Corp
Tax Payment(F)Direct1.5K shares at avg. $6.64$10K - Feb 11, 2025OPRX
OptimizeRx Corp
Exercise(M)Direct4K shares- - Feb 11, 2025OPRX
OptimizeRx Corp
Tax Payment(F)Direct1.4K shares at avg. $5.60$8K - Dec 23, 2024OPRX
OptimizeRx Corp
Award(A)Direct41.4K shares- - Dec 20, 2024OPRX
OptimizeRx Corp
Tax Payment(F)Direct1.2K shares at avg. $4.75$5K - Dec 19, 2024OPRX
OptimizeRx Corp
Exercise(M)Direct3.9K shares- - Nov 8, 2024OPRX
OptimizeRx Corp
Exercise(M)Direct1.8K shares- - Nov 8, 2024OPRX
OptimizeRx Corp
Tax Payment(F)Direct524 shares at avg. $6.27$3K - Oct 3, 2024OPRX
OptimizeRx Corp
Tax Payment(F)Direct2K shares at avg. $7.83$15K - Oct 3, 2024OPRX
OptimizeRx Corp
Exercise(M)Direct6.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 21, 2026 | OPRX OptimizeRx Corp | Tax Payment(F) | 1,529 | $7.71 | $11,789 | Direct |
| Aug 20, 2026 | OPRX OptimizeRx Corp | Award(A) | 57,600 | - | $0 | Direct |
| Feb 11, 2026 | OPRX OptimizeRx Corp | Tax Payment(F) | 1,386 | $9.23 | $12,793 | Direct |
| Feb 11, 2026 | OPRX OptimizeRx Corp | Exercise(M) | 4,000 | - | $0 | Direct |
| Dec 23, 2025 | OPRX OptimizeRx Corp | Tax Payment(F) | 4,051 | $12.74 | $51,610 | Direct |
| Dec 19, 2025 | OPRX OptimizeRx Corp | Exercise(M) | 3,928 | - | - | Direct |
| Dec 19, 2025 | OPRX OptimizeRx Corp | Tax Payment(F) | 1,153 | $13.51 | $15,577 | Direct |
| Oct 3, 2025 | OPRX OptimizeRx Corp | Exercise(M) | 6,649 | - | - | Direct |
| Oct 3, 2025 | OPRX OptimizeRx Corp | Tax Payment(F) | 1,952 | $18.75 | $36,600 | Direct |
| Aug 21, 2025 | OPRX OptimizeRx Corp | Award(A) | 15,625 | - | - | Direct |
| Mar 1, 2025 | OPRX OptimizeRx Corp | Tax Payment(F) | 268 | $5.18 | $1,388 | Direct |
| Mar 1, 2025 | OPRX OptimizeRx Corp | Exercise(M) | 771 | - | - | Direct |
| Feb 15, 2025 | OPRX OptimizeRx Corp | Tax Payment(F) | 1,479 | $6.64 | $9,821 | Direct |
| Feb 11, 2025 | OPRX OptimizeRx Corp | Exercise(M) | 4,000 | - | - | Direct |
| Feb 11, 2025 | OPRX OptimizeRx Corp | Tax Payment(F) | 1,386 | $5.60 | $7,762 | Direct |
| Dec 23, 2024 | OPRX OptimizeRx Corp | Award(A) | 41,408 | - | $0 | Direct |
| Dec 20, 2024 | OPRX OptimizeRx Corp | Tax Payment(F) | 1,153 | $4.75 | $5,477 | Direct |
| Dec 19, 2024 | OPRX OptimizeRx Corp | Exercise(M) | 3,927 | - | $0 | Direct |
| Nov 8, 2024 | OPRX OptimizeRx Corp | Exercise(M) | 1,785 | - | $0 | Direct |
| Nov 8, 2024 | OPRX OptimizeRx Corp | Tax Payment(F) | 524 | $6.27 | $3,285 | Direct |
| Oct 3, 2024 | OPRX OptimizeRx Corp | Tax Payment(F) | 1,952 | $7.83 | $15,284 | Direct |
| Oct 3, 2024 | OPRX OptimizeRx Corp | Exercise(M) | 6,649 | - | $0 | Direct |
1-22 of 22 transactions
About Odence-Ford Marion
Odence-Ford Marion (SEC CIK 0001845002) files insider reports with the SEC as Chief Legal & Admin Officer of OptimizeRx Corp (OPRX).
Signal8 holds 14 ownership filings by Odence-Ford Marion, all Form 4s, filed between Oct 7, 2024 and Aug 24, 2026. Those filings report 22 transactions, from Oct 3, 2024 to Aug 21, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Odence-Ford Marion's filings is in WALTHAM, MA.
Recent filings by Odence-Ford Marion
- Aug 21, 2026: Tax withholding of OPRX shares (Form 4, code F).
- Aug 20, 2026: Grant or award of OPRX shares (Form 4, code A).
- Feb 11, 2026: Tax withholding of OPRX shares (Form 4, code F).
- Feb 11, 2026: Option exercise of OPRX shares (Form 4, code M).
- Dec 23, 2025: Tax withholding of OPRX shares (Form 4, code F).
Other insiders filing for OptimizeRx Corp (OPRX)
- D'Silva Andrew J., Chief Business Officer
- Silvestro Stephen L, Chief Executive Officer
- Merrell Brendan W., CHIEF OPERATING OFFICER
- Stelmakh Edward, Chief Finance & Strat Officer
- KLEMA CATHY, Director
- Lang James Paul, Director